Usted buscó: biopharmaceuticals (Finés - Danés)

omrix biopharmaceuticals ltd.
omrix biopharmaceuticals ltd.

omrix biopharmaceuticals s. a.
omrix biopharmaceuticals s. a.

omrix biopharmaceuticals ltd plasma fractionation institute sheba hospital, tel hashomer ramat gan 52621, israel att:
omrix biopharmaceuticals ltd plasma fractionation institute sheba hospital, tel hashomer ramat gan 52621, israel att:

muita tietoja evicelistä euroopan komissio myönsi omrix biopharmaceuticals s. a.: lle koko euroopan unionin alueella voimassa olevan myyntiluvan eviceliä varten 6. 10. 2008.
europa- kommissionen udstedte en markedsføringstilladelse med gyldighed i hele den europæiske union for evicel til omrix biopharmaceuticals s. a. den 6. oktober 2008.

note for guidance on non- clinical testing of herbal drug preparations with long- term marketing experience - guidance to facilitate mutual recognition and use of bibliographic data concept paper for a note for guidance on the investigation of biopharmaceutical characterisation and bioavailability/ bioequivalence of herbal drugs/ preparations position paper on the risk associated with the use of herbal products containing estragole position paper on the risk associated with the use of herbal products containing methyleugenol position paper on the risk associated with the use of herbal products containing a - and β- asarone position paper on the use of sassafras albidum as active substance or ingredient in herbal medicinal products concept paper on the levels of scientific evidence required for the authorisation of well- established use and traditional herbal medicinal products core- data on urticae radix core- data on lini semen core- data on rosmarini folium cum flore core- data on primulae radix
note for guidance on non- clinical testing of herbal drug preparations with long- term marketing experience - guidance to facilitate mutual recognition and use of bibliographic data concept paper for a note for guidance on the investigation of biopharmaceutical characterisation and bioavailability/ bioequivalence of herbal drugs/ preparations position paper on the risk associated with the use of herbal products containing estragole position paper on the risk associated with the use of herbal products containing methyleugenol position paper on the risk associated with the use of herbal products containing á - and β- asarone position paper on the use of sassafras albidum as active substance or ingredient in herbal medicinal products concept paper on the levels of scientific evidence required for the authorisation of well- established use and traditional herbal medicinal products core- data on urticae radix core- data on lini semen core- data on rosmarini folium cum flore core- data on primulae radix